Daniel J Berlau

6PUBLICATIONS
0CO-AUTHORS
Gene and molecular therapyEnergy generation, conversion and storage (excl. chemical and electrical)Molecular medicinePharmacogenomicsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 30, 2026
Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update.

Leyken Wilson, Lucy M Johnson, Daniel J Berlau

|Feb 03, 2025
The latest developments in synthetic approaches to Duchenne muscular dystrophy.

Lucy M Johnson, Tariq G Pulskamp, Daniel J Berlau

|Aug 17, 2024
Corticosteroids for the treatment of Duchenne muscular dystrophy: a safety review.

Eszter Czifrus, Daniel J Berlau

|Sep 28, 2022
Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy.

Kelsie D Kracht, Nicole L Eichorn, Daniel J Berlau

|Mar 06, 2020
New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics.

Sharon M Grages, Michael Bell, Daniel J Berlau

|Jan 30, 2018
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.

Denise K Patten, Bob G Schultz, Daniel J Berlau

Pageof 1

Frequent Collaborators